Kekule Pharmaceuticals (A.P) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -146.22%
(FY 2023)
- Ebitda -184.98%
(FY 2023)
- Net Worth -23.43%
(FY 2023)
- Total Assets -36.44%
(FY 2023)
About Kekule Pharmaceuticals (A.P)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kudaravalli Rao, Kudaravalli Durgarani, and Srilakshmi Kudaravalli serve as directors at the Company.
- CIN/LLPIN
U24296AP2015PLC096388
- Company No.
096388
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kekule Pharmaceuticals (A.P)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kudaravalli Rao  | Director | 27-Mar-2015 | Current |
| Kudaravalli Durgarani | Director | 27-Mar-2015 | Current |
| Srilakshmi Kudaravalli | Director | 27-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Kekule Pharmaceuticals (A.P).
Kekule Pharmaceuticals (A.P) Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 146.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kekule Pharmaceuticals (A.P)?
In 2023, Kekule Pharmaceuticals (A.P) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kekule Pharma LimitedActive 40 years 20 daysKudaravalli Rao, Kudaravalli Durgarani and 1 more are mutual person
Kekule Life Sciences LimitedActive 11 years 4 monthsKudaravalli Rao and Srilakshmi Kudaravalli are mutual person
Premier Klenz Private LimitedActive 43 years 11 monthsKudaravalli Rao and Kudaravalli Durgarani are mutual person
- Dura Estates Private LimitedActive 18 years 1 month
Kudaravalli Rao and Kudaravalli Durgarani are mutual person
- Dura Lifesciences LimitedActive 16 years 10 months
Kudaravalli Rao, Kudaravalli Durgarani and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kekule Pharmaceuticals (A.P)?
Unlock and access historical data on people associated with Kekule Pharmaceuticals (A.P), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kekule Pharmaceuticals (A.P), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kekule Pharmaceuticals (A.P)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
